The drug candidate is administered orally in the form of a film-coated tablet and acts by targeting oestrogen receptors. This Phase III open-label study in early breast cancer enrols 5,500 ...

With patents expiring and the obesity market opening up, major players in the weight-loss market are lining up to see what will follow the likes of Wegovy and Zepbound. With Morgan Stanley estimating ...

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, announced results of a collaborative research program between IonQ, AstraZeneca, Amazon Web Services (AWS), and ...

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the New Drug Application ...

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...

The agency said it will evaluate whether regulatory action is needed after investigating the deaths of two patients treated with Sarepta's therapy.

Guest blog by Joachim Bjørkmann from Ministry of Foreign Affairs Denmark as part of our #UnleashInnovation week 2025.

Difference Between Report Form & Account Form Balance Sheets. Your balance sheet provides an overview of your company's financial position -- the assets the company has, ...